{"store":{"baseInfo":{"podcastTitle":"ASGBI Podcasts","slug":"asgbi","podcastDescription":"Welcome to the ASGBI podcast channel. Each exciting episode will delve into the latest advancements, insights, and discussions shaping the field of general surgery. Join us as we explore innovative techniques, share expertise, and engage with leaders in our specialty.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt_1200x628.jpg?s=51cd06a9c711c333e1ba9537d8f1d3c2&e=png","podcastUrl":"https://asgbi.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/asgbi/feed.xml","theme":"podisc","podcastDeepLink":"https://www.podbean.com/pw/pbblog-rh2ug-10626ad?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":30,"gmtAdjustment":"GMT+00:00","useDaylightTime":1,"value":0,"text":"(GMT+00:00) Greenwich Mean Time : Dublin, Edinburgh, Lisbon, London","daylightStartTime":"Last Sunday of March +1 Hours","daylightEndTime":"Last Sunday Of October +1 Hours","timezone":"Europe/London"},"podcastDownloads":null,"totalEpisodes":14,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"The Association of Surgeons of Great Britain and Ireland (ASGBI)","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-rh2ug-10626ad-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-rh2ug-10626ad?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/0DBFB43hu1jBncVcFUfNb1","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Helvetica"},{"id":"SecondaryFont","val":"Helvetica"},{"id":"PlayerColor","val":"#D89B3D"},{"id":"Favicon","val":"https://mcdn.podbean.com/mf/web/kmz9a2/favicon.png"},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#FFFFFF"},{"id":"BackgroundImage","val":"https://mcdn.podbean.com/mf/web/4mzymv/Podcasts-BG-2.jpg"},{"id":"BackgroundImageForMobile","val":"https://mcdn.podbean.com/mf/web/t65ud3/Mobile_Header1c3ac853-94c3-7b9d-6e80-af61c6ecfa8f.jpg"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"SecondaryPageBackgroundImage","val":"https://mcdn.podbean.com/mf/web/4mzymv/Podcasts-BG-2.jpg"},{"id":"SecondaryPageBackgroundImageForMobile","val":"https://mcdn.podbean.com/mf/web/nc3tg4/Mobile_Header81beb52f-408f-43b9-b248-a46f86760646.jpg"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":8},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#FFFFFF"},{"id":"NavigationBackgroundColor","val":"#D89B3D"},{"id":"NavigationSearch","val":"hide"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/aqboplFLPHj2","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-6j5nVdTzDun3","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer1"},{"id":"FooterFontColor","val":"#FFFFFF"},{"id":"FooterBackgroundColor","val":"#D89B3D"},{"id":"FooterCopyright","val":"Copyright {year} All Rights Reserved | ASGBI"},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://asgbi.podbean.com","apiCommonParams":{"t":"68521fdc","clientSignature":"4ecffb688c4242b2ecf00936b79a003e","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb22485221-b7m2k","episode":{"id":"pb22485221","idTag":"b7m2k","title":"ASGBI MA In Defence of: UK REBOA Trial - JAMA PMID: 37824132","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt_1200x628.jpg?s=51cd06a9c711c333e1ba9537d8f1d3c2&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt.png","previewContent":null,"content":"

Join the Moynihan Academy's Research Lead Jared Wohlgemut @JWohlgemut and Trauma Max Lead Marsden @MaxMarsden83 as they interview Professor Jansen on the UK REBOA Trial

\n\n

","publishTimestamp":1707217999,"duration":1230,"mediaUrl":"https://mcdn.podbean.com/mf/web/hjbasg/Podcast_16cq2u.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-b7m2k-15718e5","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-b7m2k-15718e5","transcriptUrl":null,"permalink":"/e/asgbi-ma-in-defence-of-uk-reboa-trial-jama-pmid-37824132/","downloadLink":"https://www.podbean.com/media/share/pb-b7m2k-15718e5?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":48,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-b7m2k-15718e5","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fasgbi.podbean.com%252Fe%252Fasgbi-ma-in-defence-of-uk-reboa-trial-jama-pmid-37824132%252F&rts=1979dfc422e2e7779cd47abbdc6b89790983f1c8","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb22485221","idTag":"b7m2k","title":"ASGBI MA In Defence of: UK REBOA Trial - JAMA PMID: 37824132","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt_1200x628.jpg?s=51cd06a9c711c333e1ba9537d8f1d3c2&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17180333/Podcast-Spotify_Apple_BG_Cover_mh8xpt.png","previewContent":null,"content":"

Join the Moynihan Academy's Research Lead Jared Wohlgemut @JWohlgemut and Trauma Max Lead Marsden @MaxMarsden83 as they interview Professor Jansen on the UK REBOA Trial

\n\n